ACET Message Board Post 8896472 | Adicet Bio Inc.
home / stock / acet / acet message board
Harper
(investorshub)
Posted on: Dec/07/2021 01:04:22
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167026696
14.20 in AH. Nice day for the clinical
News, Short Squeeze, Breakout and More Instantly...
-
2024-04-23 06:49:48 ET DENVER, Colo., Apr 23, 2024 ( 247marketnews.com )- Adicet Bio, Inc. (Nasdaq: ACET ) stated that a new preclinical data highlighting ADI-270 was selected for an oral presentation at the ASGCT 27th Annual Meeting on May 10, 2024 in the Targeted Gene and Cell The...
-
Preclinical findings showed robust anti-tumor activity of ADI-270 in multiple CD70-positive solid and hematological cancer models ADI-270 demonstrated enhanced functional potency and resilience in tumor microenvironment On track to file an investigational new drug (IND) applicatio...
-
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer will participate in a panel at the Canaccord Genuit...